Zifo Launches AI-Powered Antibody Engineering App on Snowflake Marketplace for Biologics and Drug Discovery
PorAinvest
jueves, 14 de agosto de 2025, 8:38 am ET1 min de lectura
SNOW--
The Antibody Engineering app integrates state-of-the-art AI models, such as ProtGPT2, ESM, and RoBERTa, into a seamless workflow. Users can fine-tune these models on their proprietary datasets within Snowflake's secure environment, generating novel antibody sequences and predicting their 3D structures. This end-to-end solution aims to improve the hit rate for high-affinity therapeutic antibodies, a significant challenge in traditional drug development.
Chris McClure, Head of Solution Services for Zifo in North America, stated, "We are entering a new era of drug discovery, one where AI and data converge to solve biology's most complex puzzles. Zifo Antibody Engineering is more than just a tool; it's a strategic partner for scientists."
The platform's value extends across the life sciences ecosystem, offering biopharma R&D teams, CDMOs, CROs, academic institutions, and clinical and preclinical development teams the ability to leverage advanced protein modeling tools. The architecture is designed for high-performance AI workloads, handling massive datasets and multi-modal inputs with ease.
Zifo's Antibody Engineering App can be downloaded from the Snowflake Marketplace. For more information, visit [Zifo Technologies](https://www.zifornd.com).
References:
[1] https://www.prnewswire.com/news-releases/zifo-launches-ai-antibody-engineering-app-on-snowflake-marketplace-to-accelerate-biologics-and-drug-discovery-302530069.html
[2] https://blockchain.news/flashnews/deeplearning-ai-launches-fast-prototyping-of-genai-apps-with-streamlit-in-partnership-with-snowflake-snow-course-now-live
Zifo has launched an AI-powered antibody engineering app on Snowflake Marketplace, enabling biopharma companies and research institutions to design and optimize therapeutic antibodies faster. The cloud-native GenAI platform, built on Snowflake Data Cloud, integrates state-of-the-art AI into an end-to-end workflow, improving the hit rate for high-affinity therapeutic antibodies. By leveraging Snowflake's platform, users can fine-tune powerful protein language models without moving sensitive information outside of their secure environment.
Zifo Technologies has announced the launch of its AI-powered Antibody Engineering application on the Snowflake Marketplace. This cloud-native GenAI platform is designed to accelerate the development of therapeutic antibodies, promising to streamline the drug discovery process and reduce costs. The platform is built on Snowflake Data Cloud, offering a secure and scalable environment for biopharma companies, research institutions, and contract research organizations to design and optimize antibodies.The Antibody Engineering app integrates state-of-the-art AI models, such as ProtGPT2, ESM, and RoBERTa, into a seamless workflow. Users can fine-tune these models on their proprietary datasets within Snowflake's secure environment, generating novel antibody sequences and predicting their 3D structures. This end-to-end solution aims to improve the hit rate for high-affinity therapeutic antibodies, a significant challenge in traditional drug development.
Chris McClure, Head of Solution Services for Zifo in North America, stated, "We are entering a new era of drug discovery, one where AI and data converge to solve biology's most complex puzzles. Zifo Antibody Engineering is more than just a tool; it's a strategic partner for scientists."
The platform's value extends across the life sciences ecosystem, offering biopharma R&D teams, CDMOs, CROs, academic institutions, and clinical and preclinical development teams the ability to leverage advanced protein modeling tools. The architecture is designed for high-performance AI workloads, handling massive datasets and multi-modal inputs with ease.
Zifo's Antibody Engineering App can be downloaded from the Snowflake Marketplace. For more information, visit [Zifo Technologies](https://www.zifornd.com).
References:
[1] https://www.prnewswire.com/news-releases/zifo-launches-ai-antibody-engineering-app-on-snowflake-marketplace-to-accelerate-biologics-and-drug-discovery-302530069.html
[2] https://blockchain.news/flashnews/deeplearning-ai-launches-fast-prototyping-of-genai-apps-with-streamlit-in-partnership-with-snowflake-snow-course-now-live
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios